Ghent University Academic Bibliography

Your filters: cql: author="Lahmer, Tobias" or (type any "bookEditor issueEditor" and editor="Lahmer, Tobias")

Add to list
- Journal Article
- A1
- open access
Beyond the usual suspects : RSV infection in patients with hematological malignancies compared to influenza and SARS‐COV‐2 : a report from the EPICOVIDEHA/EPIRESEHA registry

Jon Salmanton‐García, Francesco Marchesi, Milan Navrátil, Iker Falces‐Romero, Maria Ilaria Del Principe, Jorge Labrador, Klára Piukovics, Verena Petzer, Monika M. Biernat, Michail Samarkos, et al.

(2026) AMERICAN JOURNAL OF HEMATOLOGY. 101(2). p.365-375
Add to list
- Journal Article
- A1
- open access
Respiratory viruses in patients with hematological malignancy in boreal autumn/winter 2023–2024 : EPICOVIDEHA-EPIFLUEHA report

Jon Salmanton‐García, Francesco Marchesi, Milan Navrátil, Klára Piukovics, Maria Ilaria del Principe, Marianna Criscuolo, Yavuz M. Bilgin, Nicola S. Fracchiolla, Antonio Vena, Alessandra Romano, et al.

(2025) AMERICAN JOURNAL OF HEMATOLOGY. 100(3). p.358-374
Add to list
- Journal Article
- A1
- open access
Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients : results from the EPICOVIDEHA registry

Tommaso Francesco Aiello, Jon Salmanton-Garcia, Francesco Marchesi, Barbora Weinbergerova, Andreas Glenthoj, Jens Van Praet (UGent) , Francesca Farina, Julio Davila-Valls, Sonia Martin-Perez, Shaimaa El-Ashwah, et al.

(2024) HAEMATOLOGICA. 109(8). p.2693-2700
Add to list
- Journal Article
- A1
- open access
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies : results from the EPICOVIDEHA survey

Tobias Lahmer, Jon Salmanton-García, Francesco Marchesi, Shaimaa El-Ashwah, Marcio Nucci, Caroline Besson, Federico Itri, Ozren Jaksic, Natasha Čolović, Barbora Weinbergerová, et al.

(2024) INFECTION. 52(3). p.1125-1141
Add to list
- Journal Article
- A1
- open access
Decoding the historical tale : COVID-19 impact on haematological malignancy patients : EPICOVIDEHA insights from 2020 to 2022

Jon Salmanton-García, Francesco Marchesi, Francesca Farina, Barbora Weinbergerová, Federico Itri, Julio Dávila-Valls, Sonia Martín-Pérez, Andreas Glenthøj, Ditte Stampe Hersby, Maria Gomes Da Silva, et al.

(2024) ECLINICALMEDICINE. 71.
Add to list
Characteristics of co-infection and secondary infection amongst critically ill COVID-19 patients in the first two waves of the pandemic

Thomas De Corte (UGent) , Katharina Kohler, Maurizio Cecconi, Jan De Waele (UGent) , Andrew Conway Morris, Elie Azoulay, Massimo Antonelli, Giuseppe Citerio, Andy Conway Morris, Frantisek Duska, et al.

(2024) INTENSIVE CARE MEDICINE. 50. p.989-993
Add to list
- Journal Article
- A1
- open access
Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19 : matched-paired analysis in the EPICOVIDEHA registry

Francesco Marchesi, Jon Salmanton-García, Caterina Buquicchio, Federico Itri, Caroline Besson, Julio Dávila-Valls, Sonia Martín-Pérez, Luana Fianchi, Laman Rahimli, Giuseppe Tarantini, et al.

(2023) JOURNAL OF HEMATOLOGY & ONCOLOGY. 16(1).
Add to list
- Journal Article
- A1
- open access
Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies : a report from the EPICOVIDEHA registry

Jon Salmanton-García, Francesco Marchesi, Maria Gomes da Silva, Francesca Farina, Julio Dávila-Valls, Yavuz M. Bilgin, Andreas Glenthøj, Iker Falces-Romero, Jaap Van Doesum, Jorge Labrador, et al.

(2023) ECLINICALMEDICINE. 58.
Add to list
- Journal Article
- A1
- open access
Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients : EPICOVIDEHA findings

Giuseppe Rossi, Jon Salmanton-García, Chiara Cattaneo, Francesco Marchesi, Julio Dávila-Valls, Sonia Martín-Pérez, Federico Itri, Alberto López-García, Andreas Glenthøj, Maria Gomes da Silva, et al.

(2023) INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 137. p.98-110
Add to list
- Journal Article
- A1
- open access
B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection : a European Hematology Association Survey (EPICOVIDEHA)

Maria Stefania Infante, Jon Salmanton-García, Ana Fernández-Cruz, Francesco Marchesi, Ozren Jaksic, Barbora Weinbergerová, Caroline Besson, Rafael F. Duarte, Federico Itri, Toni Valković, et al.

(2022) FRONTIERS IN ONCOLOGY. 12.

Academic Bibliography

Beyond the usual suspects : RSV infection in patients with hematological malignancies compared to influenza and SARS‐COV‐2 : a report from the EPICOVIDEHA/EPIRESEHA registry

Respiratory viruses in patients with hematological malignancy in boreal autumn/winter 2023–2024 : EPICOVIDEHA-EPIFLUEHA report

Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients : results from the EPICOVIDEHA registry

Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies : results from the EPICOVIDEHA survey

Decoding the historical tale : COVID-19 impact on haematological malignancy patients : EPICOVIDEHA insights from 2020 to 2022

Characteristics of co-infection and secondary infection amongst critically ill COVID-19 patients in the first two waves of the pandemic

Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19 : matched-paired analysis in the EPICOVIDEHA registry

Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies : a report from the EPICOVIDEHA registry

Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients : EPICOVIDEHA findings

B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection : a European Hematology Association Survey (EPICOVIDEHA)

Contents

Support

Contact